Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2022
Anteris Technologies secures US$20 million investment
Anteris Technologies secured a US$20 million investment from Perceptive Advisors, providing funding as the company works to bring its heart valve technology to market.
2021
Anteris partners with IQVIA and CRF for FDA feasibility study
Anteris Technologies partnered with IQVIA and the Cardiovascular Research Foundation to help conduct an FDA early feasibility study of its DurAVR THV System.